A Clinical Study on the Safety and Tolerability of PL54 Injection in Adult Patients With Phenylketonuria (PKU)

NCT07672756 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Phenylketonuria (PKU)

Interventions

BIOLOGICAL: PL54

Sponsor

Chongqing Peg-Bio Biopharm Co., Ltd.